ScoreWhy is Vivanza Biosciences Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 9.99% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 10.19 times
2
Below par performance in long term as well as near term
- Along with generating -28.40% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Vivanza Biosci. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Vivanza Biosci.
-28.4%
-0.65
43.92%
Sensex
-8.4%
-0.65
12.97%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
63.57%
EBIT Growth (5y)
9.99%
EBIT to Interest (avg)
0.39
Debt to EBITDA (avg)
1.66
Net Debt to Equity (avg)
2.32
Sales to Capital Employed (avg)
2.74
Tax Ratio
27.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
3.96%
ROE (avg)
10.64%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
32
Price to Book Value
1.60
EV to EBIT
17.08
EV to EBITDA
17.08
EV to Capital Employed
1.18
EV to Sales
0.15
PEG Ratio
0.11
Dividend Yield
NA
ROCE (Latest)
4.90%
ROE (Latest)
9.17%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(9M)
Higher at Rs 106.97 cr
PAT(9M)
Higher at Rs 0.31 Cr
DEBTORS TURNOVER RATIO(HY)
Highest at 9.36 times
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.07 cr
Loading Valuation Snapshot...
Here's what is working for Vivanza Biosci.
Net Sales - Latest six months
At Rs 51.61 cr has Grown at 2,506.57%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 9.36 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.31 Cr
than preceding 12 month period ended Mar 2026 of Rs -0.85 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Vivanza Biosci.
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.07 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
